ArticleClinical cancer research : an official journal of the American Association for Cancer Research2022

FDA Approval Summary: Belzutifan for von Hippel-Lindau Disease-Associated Tumors.

Jaleh Fallah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.